Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
TTM Technologies issued a press release on October 22, 2026, announcing third quarter 2026 financial results (net sales of $1.2 billion, GAAP net income of $0.79 per diluted share, non-GAAP net income of $1.46 per diluted share) and providing fourth quarter and full-year 2026 guidance, as well as preliminary 2027 forecasts. The disclosure includes detailed GAAP and non-GAAP financial statements, segment data, and end-market breakdowns. This is a standard quarterly earnings release filed under Item 2.02 of Form 8-K.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-10-22
Item 2.02
Gentherm announced its third quarter 2026 financial results on October 22, 2026, reporting Q3 revenue of $405.1 million (up 4.4% ex-FX), a net loss of $(2.6) million, and adjusted EBITDA of $45.0 million, with updated full-year 2026 guidance reflecting the Modine Performance Technologies acquisition completed on October 1, 2026.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 85%
filed 2026-10-22
The 6-K discloses the appointment of Gary Thomas Dvorchak as an independent director and member of key committees (Compensation, Nominating and Corporate Governance, and chairperson of the latter) effective October 21, 2026. While the filing also mentions the resignation of Alberto Méndez Rebollo and the cessation of Rui Ding as CTO, the principal disclosed action is Dvorchak's appointment to fill the board vacancy and assume committee leadership roles. This is material as it affects board composition and governance structure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-10-22
Item 2.02
The filing discloses quarterly financial results for the period ended September 30, 2026, including net income of $7.4 million ($0.06 per diluted share) for Q3 2026 and Operating FFO of $37.4 million ($0.32 per diluted share), along with updated 2026 full-year guidance. The press release and quarterly financial supplement contain comprehensive financial statements and performance metrics typical of an earnings release under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
Lindsay Corporation issued a press release on October 22, 2026, announcing fourth quarter and fiscal year 2026 results for the period ended August 31, 2026, including consolidated financial statements, segment results, and management commentary.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-10-22
Item 5.02
The Human Resources and Compensation Committee adopted the Management Incentive Plan (2027 MIP) for fiscal year 2027, establishing target bonus amounts (35%-100% of base salary) and performance criteria for senior officers and named executive officers.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
Blackstone issued a press release and detailed presentation on October 22, 2026, announcing third quarter 2026 financial results, including GAAP net income of $1.3 billion for the quarter and $4.9 billion year-to-date, along with key metrics such as Fee Related Earnings, Distributable Earnings, AUM, and inflows. This is a standard quarterly earnings disclosure under Item 2.02, material to investors assessing the registrant's financial performance and operational results.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-10-22
Item 5.02
Amy Ard was appointed Chief Financial Officer effective October 21, 2026, succeeding Ryan Fiedler. Her compensation package includes a $550,000 base salary, up to 85% bonus, and a $500,000 one-time equity grant.
View raw filing on EDGAR →
8-K
Workforce Reduction
confidence 92%
filed 2026-10-22
Item 2.05
Fractyl Health adopted a plan on October 21, 2026 to reduce its workforce by approximately 45% of current headcount, with estimated severance and termination costs of approximately $2 million to be incurred primarily in Q4 2026. The reduction is part of a strategic reprioritization to focus on the Revita program and is expected to reduce quarterly cash burn by approximately 50% to approximately $8 million by end of Q2 2027.
View raw filing on EDGAR →
8-K
Exec departure
confidence 72%
filed 2026-10-22
Item 5.02
Jay Caplan, Co-Founder, President and Chief Product Officer, announced his retirement effective October 30, 2026, with severance benefits and a planned consulting arrangement.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-10-22
Item 8.01
Korro Bio disclosed preclinical results for KRRO-111, its development candidate for Alpha-1 Antitrypsin Deficiency, demonstrating >95% SERPINA1 mRNA editing and sustained restoration of functional M-AAT in repeat-dose studies. The company announced a regulatory submission expected in the first half of 2027. This is a material operational/clinical milestone for a clinical-stage biopharmaceutical company advancing a pipeline program, but does not fit the specific categories of earnings release, M&A activity, or other named event types. The disclosure would affect a reasonable investor's assessment of the company's pipeline progress and near-term regulatory pathway.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
Civista Bancshares announced preliminary unaudited earnings for Q3 and nine-month periods ended September 30, 2026, reporting net income of $16.0 million (up 25.5% year-over-year) and diluted EPS of $0.77. The press release, furnished as Exhibit 99.1, contains comprehensive financial results including net interest margin expansion, efficiency ratio improvement, and other key performance metrics typical of a quarterly earnings disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-10-22
Item 8.01
The disclosure reports a material development in an ongoing merger transaction: Lantheus and Parent (Curium US Holdings LLC) received a Second Request from the FTC on October 21, 2026, extending the HSR Act waiting period. This is a significant regulatory hurdle in the previously announced August 3, 2026 merger agreement. The Second Request materially affects the timing and completion risk of the transaction, which remains a core M&A activity event even though it is an update rather than the initial announcement.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-10-22
The 6-K furnishes the results of BHP Group Limited's 2026 Annual General Meeting held on 22 October 2026, disclosing poll voting outcomes on 14 resolutions including director elections, remuneration report adoption, and equity grants. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, material because director elections and executive compensation approvals affect governance and investor assessment of the company's leadership and pay practices.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-10-22
This is a press release announcing LG Display's Q3 2026 unaudited earnings results, including revenues of KRW 6.28 trillion, operating profit of KRW 250.6 billion, and net profit of KRW 755.6 billion. The document explicitly states "LG Display Reports Third Quarter 2026 Results" and provides detailed financial performance metrics comparing quarter-on-quarter and year-on-year results. This is a discrete earnings announcement event, not a periodic financial report filing.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
United Bankshares announced third quarter and nine-month 2026 financial results on October 22, 2026, disclosing earnings of $128.7 million ($0.94 per diluted share) for Q3 2026 and $384.3 million ($2.77 per diluted share) for the nine-month period. The press release, furnished as Exhibit 99.1 under Item 2.02, provides detailed comparisons to prior quarters and year-ago periods, including net interest income, provision for credit losses, noninterest income and expense, and tax rates—all core financial metrics material to investors.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-10-22
Item 8.01
Suburban Propane Partners declared an increase in its quarterly distribution from $0.325 to $0.35 per Common Unit, representing a 7.7% increase in the annualized distribution rate to $1.40 per unit, payable November 10, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
The filing discloses the appointment of Peter Radovich as a director of MBX Biosciences effective October 20, 2026, upon recommendation of the Nominating and Corporate Governance Committee. While the disclosure includes compensatory details (stock option grant and cash compensation), the principal disclosed action is the appointment itself—a person taking a board role. This is material as it affects the composition and governance of the company's board of directors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
Norfolk Southern disclosed third quarter 2026 financial results via press release, reporting record quarterly revenues of $3.5 billion, income from railway operations of $1.2 billion, operating ratio of 67.4%, and diluted EPS of $3.37.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-10-22
Item 2.02
The filing discloses a press release announcing financial results for the third quarter ended September 30, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard earnings release disclosure, which is material to investors as it provides periodic financial performance information.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
Pool Corporation issued a press release on October 22, 2026 reporting third quarter 2026 financial results, including net sales of $1.5 billion (4% increase), operating income of $172.2 million (3% decrease), and diluted EPS of $3.40, along with confirmation of full-year adjusted diluted EPS guidance of $10.87 to $11.17.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-10-22
Item 7.01
Flutter announced it will release its third quarter 2026 financial results on November 4, 2026, and host a conference call for management to review results. This is a standard earnings announcement disclosing the timing and logistics of quarterly financial results disclosure, which is material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 75%
filed 2026-10-22
Item 2.02
CBIZ disclosed quarterly financial results, incorporating by reference a press release and financial information. The disclosure includes an adjustment for approximately $15 million in additional one-time legal expenses identified during quarter-end closing procedures that were not reflected in the prior Form 8-K announcement, with a $10.5 million after-tax impact to reported net income.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-10-22
Item 8.01
The filing discloses that on October 21, 2026, the Department of Justice and Federal Trade Commission granted early termination of the HSR Act waiting period, satisfying a key closing condition for MarketAxess' merger with Intercontinental Exchange. This represents material progress toward completion of a previously announced acquisition, with the registrant surviving as a wholly owned subsidiary of the acquirer. The disclosure is a direct update on M&A activity status.
View raw filing on EDGAR →
8-K
Financial Other
confidence 85%
filed 2026-10-22
Item 8.01
The filing discloses the Company's quarterly NAV per share ($27.72 as of September 30, 2026), updated purchase prices for its ongoing private placement offering tied to that NAV, and September 2026 dividend declarations ($0.1449 per share). While NAV disclosure and dividend declarations are routine for REITs, the combination of NAV update, private offering pricing adjustments, and dividend information would affect a reasonable investor's assessment of share value and investment returns. This is a financial disclosure that does not fit the specific categories of earnings_release, debt_issuance, or dividend_distribution alone, as it encompasses multiple financial components central to the fund's valuation and investor pricing.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-10-22
Item 2.01
Data I/O Corporation completed its acquisition of V-TEK, Inc. and A&J Programming, Inc. for approximately $23 million ($20 million cash and $3 million in common stock), described as a transformational acquisition expected to double revenue and expand into new markets including data center, AI, photonics, aerospace, and defense.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-10-22
Item 3.02
Data I/O Corporation issued $3 million in unregistered common stock to V-TEK's selling shareholders as part of the acquisition consideration, relying on Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
MSGS Spinco, Inc. elected eleven directors to its board of directors effective immediately following the spin-off distribution by MSG Sports, establishing the initial board composition of the newly independent public company with directors including Joseph M. Cohen, Stephen C. Mills, Nelson Peltz, Hans Vestberg, and James L. Dolan designated across Class A and Class B stock classes.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-10-22
Item 2.02
Item 2.02 discloses Byline Bancorp's third quarter 2026 financial results through a press release (Exhibit 99.1) announcing net income of $41.8 million and diluted EPS of $0.94, along with detailed financial statements and performance metrics. This is a standard quarterly earnings release disclosure, the primary purpose of Item 2.02.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-10-22
Item 1.01
Amendment No. 11 to the Company's Senior Secured Credit Agreement permits issuance of secured junior lien notes and amends certain covenants, including a waiver of the Current Ratio requirement through December 31, 2026, signaling material changes to the Company's capital structure and financial obligations.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 85%
filed 2026-10-22
Item 5.02
Executive officers and employees acquire non-operating working interests in oil and gas wells through the Wellbore Participation and Assignment Plan, providing equity-like interests in well operations and cost-sharing arrangements that align compensation with company performance across 38 wells in North Dakota and Montana.
View raw filing on EDGAR →
8-K
Covenant Breach
confidence 85%
filed 2026-10-22
Item 8.01
The filing discloses a Forbearance Agreement and Limited Waiver to Indentures dated September 10, 2026, with successive extensions of the forbearance period through November 1, 2026. A forbearance agreement is a creditor's agreement to temporarily waive enforcement of debt covenants or defaults, indicating the company has triggered or is at risk of triggering a covenant breach or technical default. The repeated extensions signal ongoing financial stress and a direct obligation to cure or negotiate with debt holders.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
Enova issued a press release on October 22, 2026, announcing consolidated financial results for Q3 2026 (three months ended September 30, 2026). The disclosure reports key metrics including revenue of $1.01 billion (up 26% YoY), diluted EPS of $4.06 (up 34% YoY), and adjusted EPS of $4.48 (up 33% YoY), along with originations, receivables, and credit performance data. This is a standard quarterly earnings release filed under Item 2.02, which is material to investors assessing the company's financial performance and operational trends.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-10-22
Item 8.01
The FDA's lifting of the clinical hold on ARD-101 is a material regulatory milestone that permits resumption of clinical development for Aardvark's lead program in Prader-Willi Syndrome. This is a significant operational and regulatory event—not a specific named type like earnings, M&A, or litigation—that directly affects the company's ability to advance its pipeline and would materially impact investor assessment of the registrant's prospects.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-10-22
Item 2.02
The filing discloses preliminary financial results for fiscal Q1 2027 (quarter ended September 30, 2026) via a press release, with the company announcing that "revenues and Adjusted EBITDA will exceed the high end of its previously provided guidance ranges." This is a classic earnings guidance disclosure under Item 2.02, material to investors assessing the company's financial performance and operational trajectory.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-10-22
Item 5.02
Edward M. Nigro, the Company's founder and Executive Chairman and Chief Executive Officer since 2007/2017, tendered his resignation effective immediately on October 22, 2026. While the filing also discloses Jeffrey K. Newgard's appointment as President and CEO, the principal disclosed action centers on Nigro's departure from executive leadership roles—a material event given his founding status and long tenure leading the organization's growth from $22 million to $1.4 billion in assets.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
Boston Beer disclosed third-quarter 2026 financial results on October 22, 2026, including net revenue of $520.1 million (down 3.2%), GAAP diluted EPS of $4.21, and non-GAAP diluted EPS of $4.37, along with full-year 2026 guidance updates. The filing explicitly states "The Boston Beer Company, Inc. (NYSE: SAM), today reported financial results for the third quarter ended September 26, 2026" and includes a complete earnings release as Exhibit 99.1, which is the hallmark of an earnings_release disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
SS&C Technologies announced Q3 2026 financial results on October 22, 2026, disclosing GAAP revenue of $1,690.0 million (up 7.8%), diluted EPS of $0.83, and adjusted diluted EPS of $1.78 (up 14.8%). The press release and earnings presentation are furnished as Exhibits 99.1 and 99.2, which is the standard format for earnings releases under Item 2.02. The disclosure includes detailed financial statements, operating metrics, and forward guidance for Q4 2026 and full-year 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
National Bankshares, Inc. issued a press release on October 22, 2026, reporting financial results for the nine months and three months ended September 30, 2026. The disclosure includes net income figures ($15.50 million for nine months, $5.49 million for Q3), earnings per diluted share ($2.43 and $0.86 respectively), total assets ($1.78 billion), and detailed commentary on net interest income, noninterest income, noninterest expense, and other financial metrics. This is a standard quarterly earnings release furnished as an exhibit under Item 2.02, which is the designated Item for results of operations and financial condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-10-22
Item 2.02
The filing discloses a press release announcing a conference call to discuss the Partnership's Third Quarter 2026 results. Although the actual financial results are not yet disclosed in this announcement, the press release is a standard earnings announcement mechanism that notifies investors of the timing and access details for the earnings discussion. This is a material disclosure under Item 2.02 that would affect a reasonable investor's assessment of the registrant's financial performance.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-10-22
Item 8.01
The Company issued an unsecured promissory note in the principal amount of up to $540,000 to its sponsor on June 18, 2026, with $300,000 outstanding as of October 21, 2026. This constitutes creation of a direct financial obligation meeting the definition of debt_issuance. While the note is sponsor-related and non-interest-bearing, it represents a material financing arrangement for a SPAC managing its trust account and business combination timeline.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-10-22
EX-99.1
This news release announces exploration progress at the Mustang Gold and Silver Property, including extension of the target zone, completion of an IP survey, acquisition of drill permits from the BLM, and confirmation of historic sampling results with new trench sampling (15 of 25 samples exceeding 0.100 g/t Au). The disclosure also reports staking of 54 new federal lode claims and grant of incentive stock options to directors and consultants. These are operational and strategic exploration milestones material to a mineral exploration company's advancement of its properties, though not a discrete M&A transaction, executive change, or financial event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-10-22
Item 2.02
This is a clear earnings release disclosing quarterly and year-to-date financial results for Farmers & Merchants Bancorp for the three and nine months ended September 30, 2026. The press release reports net income of $11.5 million for Q3 2026 (up 30.3% year-over-year) and $32.9 million for the nine-month period (up 39.8% year-over-year), along with comprehensive income statement, balance sheet, and operational metrics. The filing includes detailed consolidated financial statements and management commentary on profitability, capital management, and dividend increases.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-10-22
Item 5.02
Bronislaw E. Masojada resigned from the Board of Directors and from the Audit Committee and Compensation Committee effective immediately on October 21, 2026, due to his election as Lord Mayor of London. This is a clear departure of a director from the Board and its committees, making it a material executive departure disclosure under Item 5.02(b).
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-10-22
Item 5.02
The disclosure centers on Stephen C. Ruffini's appointment as Executive Vice President, Mergers & Acquisitions, effective October 16, 2026. While the section is titled "Compensatory Arrangements" and includes detailed compensation terms (base salary of $400,000, bonus and equity targets, severance provisions), the principal disclosed action is the appointment of a named executive to a new officer role. The compensation details are ancillary to the appointment itself.
View raw filing on EDGAR →
6-K
Exec departure
confidence 95%
filed 2026-10-22
EX-99.1
Thomas Lynch, PhD, Chief Business Officer, departed MindWalk Holdings Corp. effective October 16, 2026. The press release explicitly states he "has departed the company and ceased to serve as Chief Business Officer." This is a clear executive departure of a named officer. The materiality is heightened by the forward-looking statements acknowledging risks around "the transition of business development and commercial responsibilities following the departure of the Chief Business Officer" and the company's ability to "attract, retain, and integrate executive and commercial talent."
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 93%
filed 2026-10-22
Item 2.02
Disc Medicine announced and priced an underwritten public offering of 6,000,000 shares of common stock at $75.00 per share, raising approximately $450 million in gross proceeds (with expected net proceeds of approximately $422.4 million), plus a 30-day underwriter option to purchase an additional 900,000 shares. This registered equity issuance is material to existing shareholders due to dilution and represents a significant capital raise for the clinical-stage biopharmaceutical company.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-10-22
Item 8.01
This disclosure reports the consummation of an IPO and concurrent private placement by a blank-check SPAC (Frazier Life Sciences Acquisition Corp. II), with $75 million in gross IPO proceeds and $3 million in private placement proceeds placed in trust. While the IPO itself is a capital-raising event, the 8-K Item 8.01 disclosure focuses on post-closing trust account mechanics and financial position rather than the IPO announcement itself (which would typically be Item 2.01 or a press release). The audited balance sheet and detailed trust account provisions suggest this is a routine post-IPO disclosure of financial position and governance structure for a newly public SPAC, making it operational/financial in nature but not fitting neatly into a specific event category.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-10-22
SK hynix clarifies that its subsidiary Solidigm has discontinued its review of pre-IPO capital raising and IPO plans after previously considering such financing measures. This is a material operational/strategic decision affecting the company's capital structure and subsidiary's growth trajectory, but does not fit a discrete event category (not a debt issuance, dilutive issuance, or M&A activity completed). The decision to abandon a significant financing initiative would affect investor assessment of the company's capital strategy and Solidigm's competitive positioning.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-10-22
Item 7.01
The filing discloses a material acquisition in progress: Black Hills Corporation and NorthWestern Energy Group have a proposed merger pending final regulatory approval from the Montana Public Service Commission (expected before November 12, 2026). The press release announces the anticipated name and ticker symbol of the combined entity ("Bright Horizon Energy Corporation" trading as "HZN"), contingent on merger completion. This is a change-of-control transaction that has already received shareholder and multi-state regulatory approvals and is in the final stages of completion, making it a material M&A event under Item 1.01/2.01.
View raw filing on EDGAR →